Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt

Digestion

Volumn 83, Issue 1-2, 2010, Pages 24-31

  Biecker, Erwin ^a   Hausdörfer, Iris ^a   Grünhage, Frank ^a   Strunk, Holger ^a   Sauerbruch, Tilman ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cirrhosis; Critical flicker frequency; Minimal hepatic encephalopathy; Portal hypertension; Transjugular intrahepatic portosystemic shunt

Indexed keywords

BILIRUBIN; BIOCHEMICAL MARKER; CREATININE; LACTULOSE; ORNITHINE ASPARTATE;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ANALYZER; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICAL FLICKER FUSION; DISEASE MARKER; DISEASE SEVERITY; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMODYNAMIC PARAMETERS; HEPATIC ENCEPHALOPATHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; NONALCOHOLIC FATTY LIVER; PORTAL VEIN BLOOD PRESSURE; PRESSURE GRADIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SCORING SYSTEM; SURGICAL RISK; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADULT; AGED; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROSPECTIVE STUDIES; PSYCHOMETRICS;

EID: 77956606882     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000288522     Document Type: Article

References (31)

1. Pomier-Layrargues G: TIPS and hepatic en-cephalopathy. Semin Liver Dis 1996; 16:315-320.
2. Conn HO, Leevy CM, Vlahcevic ZR, Rodg-ers JB, Maddrey WC, Seeff L, Levy LL: Comparison of lactulose and neomycin in the treatment of chronic portal-systemic en-cephalopathy. A double-blind controlled trial. Gastroenterology 1977; 72:573-583.
3. Ortiz M, Jacas C, Cordoba J: Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005; 42(suppl):S45-S53.
4. Amodio P, Montagnese S, Gatta A, Morgan MY: Characteristics of minimal hepatic en-cephalopat hy. Metab Brain Dis 20 04; 19: 253-267.
5. Mehndiratta MM, Sood GK, Sarin SK, Gupta M: Comparative evaluation of visual, so-matosensory, and auditory evoked potentials in the detection of subclinical hepatic en-cephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol 1990; 85: 799-803.
6. Yen CL, Liaw YF: Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalop-athy. Hepatogastroenterology 1990; 37: 332-334.
7. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D: Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357-366.
8. Romero-Gomez M, Cordoba J, Jover R, del Olmo JA, Ramirez M, Rey R, De Madaria E, Montoliu C, Nunez D, Flavia M, Company L, Rodrigo JM, Felipo V: Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45:879-885. (Pubitemid 46631556)
9. Sharma P, Sharma BC, Puri V, Sarin SK: Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47:67-73.
10. Sarfeh IJ, Rypins EB: Partial versus total por-tacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg 1994; 219 : 353-361.
11. De Franchis R: Evolving consensus in portal hypertension. Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176.
12. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V: The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepa-tology 2003; 38: 258-266.
13. Weissenborn K, Ruckert N, Hecker H, Manns MP: The number connection tests a and b: interindividual variability and use for the assessment of early hepatic encephalopa-thy. J Hepatol 1998; 28:646-653.
14. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T: Long-term outcome after transjugular intrahepat-ic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47:288-295.
15. Mamiya Y, Kanazawa H, Kimura Y, Narahara Y, Yamate Y, Nakatsuka K, Sakamoto C: Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Hepatol Res 2004; 30:162-168.
16. Nolte W, Wiltfang J, Schindler C, Munke H, Unterberg K, Zumhasch U, Figulla HR, Werner G, Hartmann H, Ramadori G: Portosys-temic hepatic encephalopathy after trans-jugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 1998; 28:1215-1225.
17. Masson S, Mardini HA, Rose JD, Record CO: Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM 2008; 101:493-501.
18. Stefankova J, Huleki P, Babu A, Cermakova E, Safka V, Stefanek J, Fejfar T, Krajina A: Hepatic encephalopathy due to TIPS - retrospective study. Hepatogastroenterology 2007; 54:480-484.
19. Lebrec D, Giuily N, Hadengue A, Vi lgrain V, Moreau R, Poynard T, Gadano A, Lassen C, Benhamou JP, Erlinger S: Transjugular in-trahepatic portosystemic shunts. Comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996; 25:135-144 .
20. Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE: The transjugular intra-hepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-1197.
21. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, Escorsell A, Rodriguez-Laiz JM, Gilabert R, Feu F, Schorlemer C, Echenagusia A, Rodes J: Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114:1296-1303. (Pubitemid 28243916)
22. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, Berger E, Blum U, Gabelmann A, Hauenstein K, et al: The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-171. (Pubitemid 24026884)
23. Jabbour N, Zajko AB, Orons PD, Irish W, Bartoli F, Marsh WJ, Dodd GD 3rd, Ald-reghitti L, Colangelo J, Rakela J, Fung JJ: Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl Surg 1996; 2: 139-147.
24. Hassoun Z, Deschenes M, Lafortune M, Du-fresne MP, Perreault P, Lepanto L, Gianfelice D, Bui B, Pomier-Layrargues G: Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy. Am J Gas-troenterol 2001; 96:1205-1209.
25. Riggio O, Angeloni S, Salvatori FM, De San-tis A, Cerini F, Farcomeni A, Attili AF, Mer-li M: Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 2008; 103: 2738-2746.
26. Kircheis G, Bode JG, Hilger N, Kramer T, Schnitzler A, Haussinger D: Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation. Eur J Gastroenterol Hepatol 2009; 21: 1383-1394.
27. Rossle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein K H, Geiger R, Stiepak C, Keller W, Blum H E : Randomised trial of transjugular-intrahe-patic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997; 349: 1043-1049.
28. Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bachetti P, Roberts JP, Lake JR: Hepatic encephalopathy after tran-sjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroen-terol 1995; 90:549-555.
29. Cabrera J, May nar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, Rodriguez San-Roman JL, Guerra C, Kravetz D: Transjugu-lar intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 19 96; 110 : 832-839.
30. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP 3rd, Luketic VA, Cheatham AK: Portosystemic encephalopathy after trans-jugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20:46-55.
31. Riggio O, Merlli M, Pedretti G, Servi R, Med-di P, Lionetti R, Rossi P, Bezzi M, Salvatori F, Ugolotti U, Fiaccadori F, Capocaccia L: Hepatic encephalopathy after transjugular in-trahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996; 41:578-584.